Skip to content

Clinical Evaluation of GRAPE Model for Gastric Cancer Screening

Clinical Evaluation of GRAPE Model for Gastric Cancer Screening

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07067983
Enrollment
1000000
Registered
2025-07-16
Start date
2025-05-30
Completion date
2026-12-31
Last updated
2025-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric Cancer

Brief summary

A Prospective Study Evaluating the Performance of the GRAPE Model in Gastric Cancer Screening and Its Detection Rates Across Different Disease Stages

Interventions

DIAGNOSTIC_TESTResults following systematic screening

The GRAPE model's output (positive or negative) determines whether patients require follow-up gastroscopy

Sponsors

Zhejiang Cancer Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Aged between 18 and 80 years * Individuals undergoing thoracoabdominal CT examination * Voluntarily participated in the study and provided written informed consent

Exclusion criteria

* Patients with confirmed diagnosis of gastric cancer * Individuals with severe intellectual disabilities or communication disorders

Design outcomes

Primary

MeasureTime frameDescription
GRAPE systematic screening resultsfirst visited at baselineScreen-positive individuals after GRAPE systematic screening

Countries

China

Contacts

Primary ContactXiangdong Cheng
chengxd@zjcc.org.cn0086-571-881280
Backup ContactCan Hu
chengxd@zjcc.org.cn13968032995

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026